Roundup Cancer Lawsuit News

Municipalities Should Not Be So Quick To Ban Roundup Herbicide

If there is one thing I know for sure it is that Monsanto's next defoliant chemical will be even deadlier than Roundup

Friday, August 23, 2019 - As evidence mounts as to Roundup's toxicity, municipal governments in the United States and around the world are feeling the pressure to ban the herbicide when the chemical's usage is purely elective. Twenty mayors in towns across France have defied their federal government and taken it upon themselves to ban glyphosate, according to France like all other countries has distinguished between using glyphosate on municipal properties to improve their appearance and the economic consequences a country-wide ban would have if farmers could no longer use Roundup to control weeds. Several municipalities in the US states of California and Florida have also banned glyphosate. When one compares the amount of Roundup used by municipalities to that of farmers the ratio is like a drop of sand on the beach. Frances powerful farmers union, like all other farm unions in the world, opposes banning glyphosate. "Farmers' unions opposed the ban, saying there are no viable alternatives for the chemical and that a transition to organic farming is too costly." Roundup cancer lawyers representing American families and individuals harmed by product liability and have vast experience in this field offering free consultations and no obligation to file a lawsuit claim.

There is an argument to be made that the devil you know is better than the one you do not and who knows what deadly alternative herbicide Monsanto will develop next to replace Roundup. For over 100 years, Monsanto scientists have designed one form of cancer-causing chemical after another from Saccharine, to DDT, to Agent Orange, to Roundup and now they are planning the next. At the 2019 Bayer shareholder meeting, the chairman of Monsanto/Bayer announced that the company has pledged over $6 billion to be invested in developing alternative herbicides should Roundup be recalled or forced to warn consumers.

As the number of lawsuits against Monsanto/Bayer approaches 20,000 company executives are searching for answers that include possibly settling the cases for billions of dollars. To date, all three plaintiffs have been successful in their claims that Roundup herbicide causes non-Hodgkin's lymphoma, a rare but deadly form of cancer. Three our of three juries have agreed with plaintiffs, occupational users of Roundup like farmers, government outdoor maintenance workers, and gardeners that direct skin contact with Roundup leads to cancer. Bayer has continuously and vigorously denied that glyphosate, the active ingredient in Roundup herbicide is carcinogenic yet science has shown that when glyphosate is mixed with chemical surfactants in Roundup, the herbicide's toxicity is increased and the mixture is more easily absorbed into human skin and bio-accumulates to carcinogenic levels. Bayer has fought all attempts made by consumer groups to pull the product from shelves pending further testing and has fought hard to avoid placing a cancer warning label on Roundup.

The next trial against Monsanto/Bayer has been pushed ahead to January of 2020 and will take place in Monsanto's home town of St. Louis Missouri, a notoriously plaintiff-friendly venue. For the first time, Monsanto executives will be required to testify if called by the plaintiff.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.